Siemens Healthineers (OTCMKTS:SMMNY) Trading Up 1.7% – Time to Buy?

Shares of Siemens Healthineers AG (OTCMKTS:SMMNY) traded up 1.7% during mid-day trading on Thursday . The stock traded as high as $24.98 and last traded at $24.98. 67,721 shares traded hands during trading, a decline of 31% from the average session volume of 98,674 shares. The stock had previously closed at $24.56.

Wall Street Analysts Forecast Growth

SMMNY has been the subject of a number of analyst reports. Sanford C. Bernstein raised Siemens Healthineers to a “strong-buy” rating in a report on Tuesday, January 13th. Deutsche Bank Aktiengesellschaft cut Siemens Healthineers from a “buy” rating to a “hold” rating in a research report on Thursday, December 4th. Citigroup reiterated a “buy” rating on shares of Siemens Healthineers in a research report on Friday, January 23rd. Royal Bank Of Canada began coverage on shares of Siemens Healthineers in a research note on Wednesday, December 17th. They issued a “moderate buy” rating on the stock. Finally, Zacks Research raised shares of Siemens Healthineers from a “strong sell” rating to a “hold” rating in a report on Monday, January 12th. Three equities research analysts have rated the stock with a Strong Buy rating, two have given a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Buy”.

Siemens Healthineers Stock Performance

The company has a 50-day moving average of $25.60 and a 200 day moving average of $26.37.

About Siemens Healthineers

Siemens Healthineers AG is a leading global medical technology company that develops, manufactures and distributes a broad range of products and services for the healthcare sector. Headquartered in Erlangen, Germany, the company focuses on diagnostic and therapeutic imaging, in vitro diagnostics and advanced digital health solutions. As a spin-off from Siemens AG, Siemens Healthineers has leveraged decades of engineering expertise to establish a comprehensive portfolio that addresses critical needs in modern healthcare.

The company’s core offerings include magnetic resonance imaging (MRI), computed tomography (CT), X-ray and molecular imaging systems, as well as laboratory diagnostics equipment and point-of-care testing devices.